Versant Venture Capital II, LP

CIK 1354131 · last filed 2014-11-12

Versant Venture Capital II, LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider sold $1.7M of INGN on Nov 12, 2014. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $96.6K across reported positions. The firm reports its address in San Francisco, CA. 45 SEC filings were submitted jointly with Versant Affiliates Fund II-A, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$96.6K

Companies

Total Filings

Lifetime Open-Market Net

-$3.15M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

INGN price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO, CA 94104

Phone

(650) 233-7877

State of Incorporation

Related Filers

Versant Affiliates Fund II-A, LP — 45 joint filings, latest 2015-05-11

Versant Side Fund II, LP — 45 joint filings, latest 2015-05-11

Versant Ventures II LLC — 43 joint filings, latest 2015-05-11

Rebecca B Robertson — 30 joint filings, latest 2015-05-11

Ross A Md Jaffe — 24 joint filings, latest 2015-05-11

Brian G Atwood — 20 joint filings, latest 2015-05-11

Samuel D Colella — 20 joint filings, latest 2015-05-11

William J Phd Link — 20 joint filings, latest 2015-05-11

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
INGN	10%+ Owner	13,640	$7.08	$96.6K	-$3.15M	3	2014-11-12
KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted	10%+ Owner	43,583	—	—	$0	1	2012-10-16
HELICOS BIOSCIENCES CORP (HLCS) Delisted	10%+ Owner	196,522	—	—	$0	1	2008-12-29

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2014-11-12	INGN	Sell (S)	−69,096	-$1.69M	EDGAR
2014-10-09	INGN	Mixed	−275,240	-$1.45M	EDGAR
2014-02-21	INGN	Conv (C)	+14,998,052	$0	EDGAR
2012-10-16	KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted	Mixed	+11,925,255	$2.2K	EDGAR
2008-12-29	HELICOS BIOSCIENCES CORP (HLCS) Delisted	Buy (P)	+60,344,830	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.